Page last updated: 2024-10-15

3-hydroxykynurenine and Glioma

3-hydroxykynurenine has been researched along with Glioma in 1 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Vázquez Cervantes, GI1
Pineda, B1
Ramírez Ortega, D1
Salazar, A1
González Esquivel, DF1
Rembao, D1
Zavala Vega, S1
Gómez-Manzo, S1
Pérez de la Cruz, G1
Pérez de la Cruz, V1

Other Studies

1 other study available for 3-hydroxykynurenine and Glioma

ArticleYear
Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas.
    Cells, 2021, 08-08, Volume: 10, Issue:8

    Topics: Adult; Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Enzymolog

2021